The GLP-1 receptor agonist liraglutide used to treat patients with type 2 diabetes (T2D) for 26 weeks had no impact on bone resorption, even though subjects lost weight.
A 38-year-old woman went to the doctor with several complaints that seemed unrelated but they had started within the last few months. She was feeling depressed and fatigued with tingling and numbness in her hands and feet. Can you diagnose this patient?
The U.S. Food and Drug Administration has approved an omega-3 fatty acid treatment as an add-on treatment to statin therapy to reduce the risk of cardiovascular disease in adults with elevated triglyceride levels.
Insulin resistance is independently associated with body mass index (BMI) and synovitis in rheumatoid arthritis patients, shows new research published in Arthritis and Rheumatology.
A mother brought her 7-year-old boy to the eye doctor after he complained for several months about increasing photophobia during outdoor activities like soccer practice and playground outings. She also noticed that he had been thirstier than usual during his soccer games, but wasn’t sweating as much as he usually did. During the slit lamp exam, the doctor noted crystals throughout his cornea and conjunctiva. What's your diagnosis?
Postmenopausal women who participate in vigorous physical activity have a lower risk of total and hip fractures, but higher knee fracture risk, say researchers recently writing in JAMA Network Open.
In this slideshow, we review 10 new drugs or new indications for diabetes and other endocrine conditions.
A JAMA study finds that treating elderly patients who have subclinical hypothyroidism does not improve hypothyroid symptoms or fatigue.
A literature review published in JAMA Internal Medicine finds that many medical tests are overused and overtreatment is common and potentially harmful.
In this month's "Endocrine Feedback" column, Dr. Melissa Young explores how her career has evolved over the years and questions what the future may hold.